Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients (COMPETE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03049189

Recruitment Status : Recruiting

First Posted : February 9, 2017

Last Update Posted : December 10, 2020

See Contacts and Locations

Sponsor:

Collaborators:

ABX CRO

PSI CRO AG

Information provided by (Responsible Party):

ITM Solucin GmbH

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	December 2023
Estimated Study Completion Date :	May 2024

To Top